Contracts › 75A50124C00010
75A50124C00010: Development of a Novel Pralidoxime Chloride Auto-Injector Device
Awarded to Kaleo, Inc. by Office of Assistant Secretary for Preparedness and Response.
$33.3Mobligated
$33.8Mpotential value
31 October 2028current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75A50124C00010 |
|---|---|
| Awardee | Kaleo, Inc. |
| Awarding agency | Office of Assistant Secretary for Preparedness and Response |
| Awarding office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 541714 Research and Development in Biotechnology (Except Nanobiotechnology) |
| PSC | AN42 Health R&D Services; Health Care - Other; Applied Research |
| Place of performance | VA |
| Offers received | 1 |
| Period of performance | 11 April 2024 to 31 October 2028 |
| Potential end | 31 October 2028 |
| Estimated recompete solicitation | ~Q2 2028 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541714 contracts · All expiring contracts · USASpending record